MEFAS, a hybrid of artesunate-mefloquine active against asexual stages of Plasmodium vivax in field isolates, inhibits malaria transmission
Open Access
- 22 September 2021
- journal article
- research article
- Published by Elsevier in International Journal for Parasitology: Drugs and Drug Resistance
- Vol. 17, 150-155
Abstract
No abstract availableKeywords
Funding Information
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2019/19708-0)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Ministério da Ciência, Tecnologia e Inovação
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (404455/2012-3, 420153/2017-9)
- Fundação de Amparo à Pesquisa do Estado do Piauí (N02/2014)
This publication has 39 references indexed in Scilit:
- Postmortem Characterization of Patients With Clinical Diagnosis of Plasmodium vivax Malaria: To What Extent Does This Parasite Kill?Clinical Infectious Diseases, 2012
- Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal studyThe Lancet, 2012
- A Major Genome Region Underlying Artemisinin Resistance in MalariaScience, 2012
- Revisiting the circulation time of Plasmodium falciparum gametocytes: molecular detection methods to estimate the duration of gametocyte carriage and the effect of gametocytocidal drugsMalaria Journal, 2010
- Artemisinin Resistance inPlasmodium falciparumMalariaNew England Journal of Medicine, 2009
- Effective and cheap removal of leukocytes and platelets from Plasmodium vivax infected bloodMalaria Journal, 2009
- Evidence of Artemisinin-Resistant Malaria in Western CambodiaNew England Journal of Medicine, 2008
- Plasmodium falciparum gametocyte dynamics in areas of different malaria endemicityMalaria Journal, 2008
- Synthesis, Antimalarial Activity, and Intracellular Targets of MEFAS, a New Hybrid Compound Derived from Mefloquine and ArtesunateAntimicrobial Agents and Chemotherapy, 2008
- Human Malaria Parasites in Continuous CultureScience, 1976